 | Novavax, Inc. | |||
| NMS : NVAX || Location: United States | ||||
$3.890.0 (0.0%) |
2.85 M | 3.81 - 3.99 | ||
| Last Updated:America/New_York | Volume | Day range |
Total Call Open Interest - | Total Put Open Interest -
Today's Total Call volume - | Total Put volume -
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 43.907 M |
| March 15, 2024 | 48.126 M |
| Feb. 29, 2024 | 52.737 M |
| Feb. 15, 2024 | 54.827 M |
| Jan. 31, 2024 | 52.092 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.46 | -1.44 | -214.89% |
| 09/30/2023 | -1.87 | -1.26 | 32.56% |
| 06/30/2023 | -1.41 | 0.58 | 141.01% |
| 03/31/2023 | -3.53 | -3.41 | 3.43% |
| 12/31/2022 | -0.94 | -2.28 | -142.97% |
NVAX Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 139.953M | Shares Float | 125.195M |
| Short Float | 43.907M | Market Cap | 544.42M |
| Institution ownership | 56.33% | Insider ownership | 4.990% |
| Earnings Date | 05/07/2024 BMO | Cash Per Share | ? |
| Trailing EPS | -5.41 | Forward EPS | -0.05 |